Cargando…
Public Policy and Pharmaceutical Innovation
Historically, new drug introductions have played a central role in medical progress and the availability of cost-effective therapies. Nevertheless, public policy toward pharmaceuticals has been characterized in recent times by increasingly stringent regulatory controls, shorter effective patent term...
Autor principal: | Grabowski, Henry G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CENTERS for MEDICARE & MEDICAID SERVICES
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191286/ https://www.ncbi.nlm.nih.gov/pubmed/10309721 |
Ejemplares similares
-
Affordable innovation: future directions in pharmaceutical policy
por: Hill, Suzanne R
Publicado: (2015) -
A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
por: Docteur, Elizabeth, et al.
Publicado: (2015) -
Educational innovations: Categories of bulletin board postings designed to increase awareness of contemporary pharmaceutical policy issues
por: Painter, Jacob T., et al.
Publicado: (2010) -
Innovation in Data Visualisation for Public Policy Making
por: Raineri, Paolo, et al.
Publicado: (2020) -
Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers
por: Garuba, Habibat A, et al.
Publicado: (2009)